SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 5/15/12 Huiheng Medical, Inc. NT 10-Q 3/31/12 1:33K Locke Lord Bi… Lidell/FA |
Document/Exhibit Description Pages Size 1: NT 10-Q Notice of a Late Filing of a Form 10-Q HTML 23K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
|
OMB Number: 3235-0058
Expires: June 30, 2012
Estimated average burden
hours per response . . . . . . . 2.50
|
|
FORM 12b-25
NOTIFICATION OF LATE FILING
|
|
SEC FILE NUMBER
|
|
CUSIP NUMBER
|
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
|
If the notification relates to a portion of the filing checked above identify the Item(s) to which the notification relates:
|
Huiheng Medical, Inc.
|
Full Name of Registrant
|
Former Name if Applicable
|
Gaoxin 7 Street South,
Keyuannan Road, Nanshan District
|
Address of Principal Executive Office (Street and Number)
|
Shenzhen Guangdong, P.R. China 51805
|
City, State and Zip Code
|
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)
|
x
|
(a)
|
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|
(b)
|
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
|
|
(c)
|
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof could not be filed within the prescribed time period.
|
SEC 1344 (04-09)
|
(1)
|
Name and telephone number of person to contact in regard to this notification.
|
|||||
86
|
75525331366
|
|||||
(Name)
|
(Area Code)
|
(Telephone Number)
|
||||
(2)
|
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
|
|||||
Yes x No ¨
|
||||||
(3)
|
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
|
|||||
Yes x No ¨
|
||||||
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
For the three months ended March 31, 2012, the Registrant is currently determining its revenues utilizing the cost recovery method which has yet to be determined. For the three months ended March 31, 2011, the Registrant previously determined its revenues utilizing the accrual method.
|
Huiheng Medical, Inc.
|
(Name of Registrant as specified in its charter)
|
Date:
|
/s/ Richard Shen | |||
Richard Shen, Chief Financial Officer
|
This ‘NT 10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
6/30/12 | ||||
Filed on / Effective on: | 5/15/12 | |||
5/14/12 | ||||
For Period End: | 3/31/12 | |||
3/31/11 | 10-Q, 10-Q/A, NT 10-Q | |||
List all Filings |